We are live on ! Find out more
DERM icon

Journey Medical
DERM

20 hedge funds and large institutions have $4.62M invested in Journey Medical in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more funds holding

Funds holding: 13 → 20 (+7)

0.8% more ownership

Funds ownership: 15.39% → 16.19% (+0.8%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

30% less capital invested

Capital invested by funds: $6.58M → $4.62M (-$1.96M)

Holders
20
Holders Change
+7
Holders Change %
+53.85%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
4
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
First Manhattan
First Manhattan
New York
+$120K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$93.9K
3
Cerity Partners
Cerity Partners
New York
+$86.7K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$75.3K
5
WAAG
Wealth Alliance Advisory Group
Kansas
+$73.3K

Top Sellers

Rank Fund Capital Flow
1
Neuberger Berman Group
Neuberger Berman Group
New York
-$121K
2
PCM
Perkins Capital Management
Minnesota
-$37.8K
3
UBS Group
UBS Group
Switzerland
-$4.24K
4
BlackRock
BlackRock
New York
-$801
Name Holding Trade Value Shares
Change 		Change in
Stake
BRF
1
B. Riley Financial
California
$2.13M – – –
OM
2
Opaleye Management
Massachusetts
$638K +$46.2K +13,560 +6%
PCM
3
Perkins Capital Management
Minnesota
$514K -$37.8K -11,100 -5%
AFG
4
American Financial Group
Ohio
$443K – – –
Neuberger Berman Group
5
Neuberger Berman Group
New York
$398K -$121K -35,430 -18%
First Manhattan
6
First Manhattan
New York
$86K +$120K +35,294 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$67K +$93.9K +27,555 New
Cerity Partners
8
Cerity Partners
New York
$63K +$86.7K +25,421 New
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$54K +$75.3K +22,094 New
WAAG
10
Wealth Alliance Advisory Group
Kansas
$53K +$73.3K +21,500 New
BRWA
11
B. Riley Wealth Advisors
Florida
$43K +$58.8K +17,250 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$41K +$21.8K +6,408 +61%
Creative Planning
13
Creative Planning
Kansas
$29K – – –
FPAS
14
Focus Partners Advisor Solutions
Missouri
$25K +$34.1K +10,000 New
BlackRock
15
BlackRock
New York
$21K -$801 -235 -3%
TRCT
16
Tower Research Capital (TRC)
New York
$12K +$10.3K +3,021 +148%
UBS Group
17
UBS Group
Switzerland
$4K -$4.24K -1,245 -46%
EIM
18
Essex Investment Management
Massachusetts
$3K – – –
Wells Fargo
19
Wells Fargo
California
– +$48 +14 +48%
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
– +$160 +47 New

DERM Hedge Fund Activity: Q3 2022 in Review

20 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Journey Medical (DERM) for Q3 2022, worth a combined $4.62M — down 30% from $6.58M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new DERM positions and 0 closed out — a net gain of 8 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was First Manhattan, opening a new position worth an estimated $120K. The largest seller was Neuberger Berman Group, cutting an estimated $121K.

  • 20 institutional investors held Journey Medical (DERM) as of Q3 2022, up from 13 in Q2 2022.
  • Funds reported $4.62M of Journey Medical stock for Q3 2022, down 30% quarter-over-quarter.
  • 8 funds opened new Journey Medical positions in Q3 2022 and 0 closed out, a net change of +8 holders.
  • The largest Journey Medical buyer in Q3 2022 was First Manhattan, an estimated $120K added.
  • The largest Journey Medical seller in Q3 2022 was Neuberger Berman Group, an estimated $121K sold.

Based on aggregated 13F filings for Q3 2022.